FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Tandem Diabetes (NASDAQ: TNDM) reported Q1 EPS of ($0.40), $0.10 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $66 million versus the consensus estimate of $47.51 million.
Our explosive growth in the first quarter was driven by strong domestic demand... More

